Results
1 -
5 of
5
(Click
here to explore results)
- Drug Discovery for Psychiatric Disorders, CHAPTER 4 Glutamatergic Approaches for the Treatment of Schizophrenia. John A. Morrow, Robert Gilfillan, Stuart A. Neale
, 2012
, Pages 56-98
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 10 Glutamate Receptor Modulators as Emergent Therapeutic Agents in the Treatment of Parkinson’s Disease. Sylvain Célanire, Benjamin Perry, Robert Lutjens, Sonia Poli, Ian J. Reynolds
, 2013
, Pages 237-265
- Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents, Chapter 3 Recent Developments in PET and SPECT Radioligands for CNS Imaging. David Alagille, Ronald M. Baldwin, Gilles D. Tamagnan
, 2012
, Pages 49-143
- Allosterism in Drug Discovery, CHAPTER 10 mGlu4 PET Ligands as Enablers of Target Biology Understanding. Zhaoda Zhang, Pekka Poutiainen, Anna-Liisa Brownell
, 2017
, Pages 220-246
- Drug Discovery for Psychiatric Disorders, CHAPTER 10 Glutamate Approaches Towards the Treatment of Mood Disorders. Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley
, 2012
, Pages 258-275